NCT00690365View on ClinicalTrials.gov

Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

CompletedOBSERVATIONAL
Enrollment

576

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Schizophrenia
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY